EPAS1/HIF2α may be a key transcriptional control target for tumor cells to respond to hypoxia, which is a characteristic of aggressive tumor cells, and is also involved in resistance to chemotherapy and ionizing radiation (Peng et al., 2017; Påhlman and Mohlin, 2018). The gene discussed is EPAS1; the disease is neoplasm.